Skip to main content
Figure 5 | Malaria Journal

Figure 5

From: A malaria vaccine candidate based on an epitope of the Plasmodium falciparum RH5 protein

Figure 5

The VLP bearing the SAIKKPVT peptide elicits antibodies that inhibit parasite invasion. (A) Pooled sera from mice immunized with the VLP displaying the SAIKKPVT peptide were tested for their ability to inhibit 3D7 invasion (concentrations used from 0.1 mg/mL to 1.0 mg/mL). Invasion inhibition ranged from 22% to 92%. Purified IgG from naïve mouse sera was used at equivalent concentrations as negative controls. Error bars show standard error. (B) Immunoblotting (left panel; expected size of native PfRH5 at ~63 kDa indicated by arrow) and (C) immunofluorescence (right panel; apical end of merozoites are indicated by FITC staining) show the PfRH5 specific VLP sera is able to recognize native PfRH5.

Back to article page